Figure Gallery

Expression Pattern Search Results for mbpa

(191 figures with expression from 110 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Zhu et al., 2020	Fig. 5	slc45a2^b4/b4	chemical treatment by environment: ponatinib	Protruding-mouth	whole organism
Admati et al., 2019	Fig. 4	WT slco1c1^biu16/biu16	standard conditions	Adult	brain
Asad et al., 2019	Fig. 1	TU + MO3-chd7 + MO8-chd7	standard conditions	Day 4	glial cell
	Fig. 5	TU + MO3-chd7 + MO8-chd7	standard conditions chemical treatment by environment: CHIC-35 chemical treatment by environment: DAPT chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide chemical treatment by environment: procainamide	Day 4	lateral line glial cell
Bradley et al., 2019	Fig. 3	AB adgrg6^st49/st49 adgrg6^st63/st63 adgrg6^stl47/stl47 adgrg6^{stl215/stl215}	control chemical treatment by environment: naloxone hydrochloride chemical treatment by environment: telmisartan chemical treatment by environment: undecenoic acid	Day 4 to Day 5	posterior lateral line nerve posterior lateral line nerve myelinating Schwann cell
	Fig. 4	AB adgrg6^st63/st63 adgrg6^{stl215/stl215}	control chemical treatment by environment: apomorphine hydrochloride chemical treatment by environment: forskolin	Day 5	posterior lateral line nerve
Diamantopoulou et al., 2019	Fig. 1	WT adgrg6^fr24/fr24 adgrg6^{tb233c/tb233c}	standard conditions	Day 4	central nervous system peripheral nervous system posterior lateral line ganglion posterior lateral line nerve
	Figure 6.	WT adgrg6^{tb233c/tb233c}	control standard conditions chemical treatment: FPL 64176 chemical treatment: cilnidipine chemical treatment: nifedipine	Day 4	central nervous system peripheral nervous system posterior lateral line ganglion posterior lateral line nerve
Gramann et al., 2019	Figure 5	WT gdf6a^s327/s327	standard conditions chemical treatment by environment: DMH1	Day 5	glial cell (sensu Vertebrata)
Lazcano et al., 2019	Fig. 7	WT WT + CRISPR1-thraa WT + CRISPR1-thrab WT + CRISPR1-thrb WT + CRISPR2-thrb	standard conditions control chemical treatment by injection: thyroid hormone	1-cell to 90%-epiboly	whole organism
Nagarajan et al., 2019	Fig. 4	WT + MO1-dhrs12la	control	Day 4	whole organism
Walter et al., 2019	Fig. 7	SPF 5-D	standard conditions	14-19 somites to Day 5	whole organism
Babu et al., 2018	Fig. 6	TU TU + MO3-ep300b TU + MO4-ep300a TU + MO3-ep300b + MO4-ep300a	control	Day 4	glial cell
Cunningham et al., 2018	Fig. 1	WT dock1^{stl145/stl145}	standard conditions	Protruding-mouth to Day 5	posterior lateral line immature Schwann cell posterior lateral line myelinating Schwann cell
	Fig. 2	WT dock1^{stl145/stl145} dock1^{stl365/stl365} dock1^{stl366/stl366} dock1^stl145/+; dock1^stl365/+ dock1^stl145/+; dock1^stl366/+	standard conditions	Protruding-mouth	posterior lateral line immature Schwann cell
Giera et al., 2018	Fig. 3-S1	AB gas6^{stl228/stl228} (AB) pals2a^{stl233/stl233} (AB) pals2b^{stl234/stl234} (AB) pleca^{stl261/stl261} (AB) plecb^{stl236/stl236} (AB)	standard conditions	Day 5	central nervous system
Meireles et al., 2018	Fig. 1	TL mtor^{xu015Gt/xu015Gt} (TL) rraga^st77/st77 (TL)	standard conditions	Day 5	central nervous system oligodendrocyte peripheral nervous system myelinating Schwann cell
	Fig. 3	TL rraga^st77/st77 (TL) tfeb^st120/+; tfeb^st121/+ (TL) rraga^st77/st77; tfeb^st120/+ (TL) rraga^st77/st77; tfeb^st120/+; tfeb^st121/+ (TL)	standard conditions	Day 5	central nervous system oligodendrocyte
	Fig. S2	TL rraga^st77/st77 (TL)	control chemical treatment by environment: torin 1	Day 5	central nervous system oligodendrocyte peripheral nervous system myelinating Schwann cell
	Fig. 4	TL tfeb^st120/+; tfeb^st121/+ (TL)	standard conditions	Days 7-13	oligodendrocyte cell body oligodendrocyte glial cell projection
Torvund-Jensen et al., 2018	Fig. 1	WT	standard conditions	Protruding-mouth to Adult	brain hindbrain lateral line spinal cord whole organism
	Fig. 3	WT	standard conditions	Day 4	whole organism
	Fig. 6	zf2108Tg zf2109Tg zf2110Tg	standard conditions	Protruding-mouth	oligodendrocyte cell body oligodendrocyte myelin sheath
Walter et al., 2018	Fig. 9	WT WT + MO1-slc16a2	standard conditions control chemical treatment by environment: 6-propyl-2-thiouracil	Day 5	whole organism
	Fig. 5	WT	standard conditions	Prim-5 to Day 5	whole organism